Clinical Trials Browser

Phase 3 × Completed × apixaban × Clear all

NCT02066454 2025-08-13

MYELAXAT

Phase 3 Completed

Classical hematologyPlasma cell

Neoplasms, Plasma Cell, Venous Thromboembolism

NCT03045406 2025-06-24

CARAVAGGIO

Phase 3 Completed

1,170 enrolled 11 charts

Classical hematology

Venous Thromboembolism

NCT03080883 2025-05-18

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Phase 3 Completed

370 enrolled 16 charts

Other hematologic neoplasm

Neoplasm Metastasis, Pulmonary Embolism, Hematologic Neoplasms, Venous Thrombosis, Intracranial Thrombosis

NCT03692065 2025-02-06

API-CAT

Phase 3 Completed

Neoplasms, Thrombosis

NCT02369653 2022-03-08

A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase

Phase 3 Completed

512 enrolled 26 charts

LymphoidOther hematologic neoplasm

Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Phase 3 Completed

300 enrolled 11 charts

Classical hematology

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia